EVAX
Evaxion Biotech AS
NASDAQ: EVAX · HEALTHCARE · BIOTECHNOLOGY
$4.41
+3.52% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
4.47x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $12
Volume
0.0M
Evaxion Biotech AS (EVAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-102.40%
Operating margin
-122.70%
ROE
-100.20%
ROA
-28.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-5.54M | — | — | — |
| 2019 | $0.00 | $-11.19M | — | — | — |
| 2020 | $0.00 | $-15.02M | — | — | — |
| 2021 | $0.00 | $-24.53M | — | — | — |
| 2022 | $0.00 | $-23.17M | — | — | — |
| 2023 | $73000.00 | $-22.13M | 100.00% | -30,406.85% | -30,308.22% |
| 2024 | $3.34M | $-10.57M | 100.00% | -440.55% | -316.00% |
| 2025 | $7.55M | $-7.73M | 99.69% | -122.66% | -102.38% |